ITGA6 and hepatocellular carcinoma: Collectively, KDM5B could activate the YTHDF3/ITGA6 pathway to enhance the proliferation and growth of tumour cells by inhibiting the expression of miR‐448 in HCC, eventually leading to the occurrence of HCC.